AUA: Sequencing of Agents and Combination of Treatment Options for Bladder Cancer

AUA University CME Available:


Co-Host: Yair Lotan, MD


At the conclusion of these activities, participants will be able to:


1. Evaluate Treatment plans including the sequencing and combination of treatment options for individual patients.


2. Facilitate discussions with patients and caregivers regarding of bladder cancer treatment options.


This educational series is supported by independent educational grants from:


Amgen
Astellas
AstraZeneca
Bristol-Myers Squibb
Genomic Health
Merck
Pfizer, Inc.
Sanofi Genzyme
UroGen Pharma


More podcasts available at:

Bladder Cancer,AUA,American Urological Association,Urology,Urologist,Urological,Cancer,Bladder,Sequencing Agents,Bladder Cancer Treatment,Medical,Med,Medicine,Doctor,educational,medical education,AUAU,American Urological Association University,